TiaraMed LP is a private equity fund based in St. Peter Port, Guernsey. Its most recent Form D, filed Sep 21, 2021, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Mid Europa IV Management Limited; John Whittle; Roger Le Tissier.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Mid Europa IV Management Limited; John Whittle; Roger Le Tissier
- Latest Form D
- Sep 21, 2021
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about TiaraMed LP
What is the minimum investment for TiaraMed LP?
TiaraMed LP's latest Form D, filed Sep 21, 2021, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in TiaraMed LP?
TiaraMed LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has TiaraMed LP raised?
TiaraMed LP's latest Form D, filed Sep 21, 2021, reports no sales yet.
Where is TiaraMed LP based?
TiaraMed LP is based in St. Peter Port, Guernsey.
Size compared with every private equity fund
This fund hasn't reported any sales yet.